We are hereby submitting the Scrutinizer''s Report for the postal ballot.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
iSERA Lifesciences Limited (formerly Covidh Technologies Limited) has successfully completed a postal ballot through remote e-voting for 7 resolutions. All resolutions were passed with overwhelming shareholder approval. The key resolutions include: (1) Increase in authorised share capital, (2) Adoption of new Memorandum of Association, (3) Adoption of new Articles of Association, (4) Enhancement of investment limits under Section 186, (5) Approval of related party transaction for acquisition of iSERA Biological Limited, (6) Acquisition of up to 100% equity of iSERA Biological Limited through share swap, and (7) Issuance of equity shares by preferential issue on private placement basis for share swap consideration. The voting took place from April 22 to May 21, 2026, with only about 29% of outstanding shares actually voting, indicating low retail participation.
Shareholders should note that the company is undergoing a significant transformation including a name change, capital restructuring, and a major acquisition of iSERA Biological Limited via share swap. The near-unanimous approval suggests strong promoter confidence, but the low voter turnout (29%) means decisions were made by a small group of large shareholders.